Clinical Trial Update: A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women [Phase 1]

View source ↗

Summary

First-in-human Phase 1 safety and pharmacokinetic study of the investigational drug GenSci142 in healthy Chinese women, with the trial status not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• GenSci142

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Bacterial Vaginosis | Phase 1 | Status: NOT_YET_RECRUITING